Pfizer Inc (PFE)

48.20
+0.29(+0.62%)
  • Volume:
    28,604
  • Bid/Ask:
    48.13/48.19
  • Day's Range:
    47.99 - 48.80
  • Type:Equity
  • Market:Germany
  • ISIN:US7170811035
  • WKN:852009

PFE Overview

Prev. Close
47.9
Day's Range
47.99-48.8
Revenue
-
Open
48.39
52 wk Range
27.51-54.57
EPS
-
Volume
28,604
Market Cap
269.15B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
205,317
P/E Ratio
-
Beta
-
1-Year Change
60.14%
Shares Outstanding
5,612,866,598
Next Earnings Date
Feb. 08, 2022
What is your sentiment on Pfizer Inc?
or
Vote to see community's results!

Pfizer Inc Company Profile

Employees
78500

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; Arvinas, Inc.; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Read More

Type
Daily
Weekly
Monthly
Moving AveragesStrong BuyBuyStrong Buy
Technical IndicatorsBuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong Buy
  • Extremely Undervalued Stock of 2021
    3
    • Pfizer Just Got 'Full FDA Approval' For Its COVID Vaccine
      2
      • PFE Market Cap: aprx 270B INV chart number is wrong!
        1
        • a correction has been made👍
          0
        • Mine Ucakhanwho will make correction
          0
      • Up to 100 very soon
        2
        • it is strong buy signal, do not wait, buy now
          1
          • Ban nha mua luon
            0
        • When is the right time to buy or sell?
          0
          • Buying time of course, very undervalued
            0
            • See moderna $235 Bill Gates is the emperor
              0
              • July 28 watch it!
                1
                • They are all thieves
                  0
                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.